Violation Tracker Individual Record
Company:Eli Lilly and Company
Date:October 7, 2008
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Eli Lilly agreed to pay $62 million to settle multistate litigation alleging that it improperly marketed the antipsychotic drug Zyprexa for uses not approved by the Food and Drug Administration.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Indiana
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.